Shanghai Pharmaceuticals Valuation
| SHPMY Stock | USD 8.20 0.32 4.06% |
At this time, the company appears to be overvalued. Shanghai Pharmaceuticals has a current Real Value of $6.67 per share. The regular price of the company is $8.2. Our model measures the value of Shanghai Pharmaceuticals from inspecting the company fundamentals such as Operating Margin of 0.04 %, return on equity of 0.1, and Shares Outstanding of 739.51 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Shanghai Pharmaceuticals' price fluctuation is moderately volatile at this time. Calculation of the real value of Shanghai Pharmaceuticals is based on 3 months time horizon. Increasing Shanghai Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Shanghai Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Shanghai Pink Sheet. However, Shanghai Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.2 | Real 6.67 | Hype 8.2 |
The intrinsic value of Shanghai Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Shanghai Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Shanghai Pharmaceuticals Holding helps investors to forecast how Shanghai pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Shanghai Pharmaceuticals more accurately as focusing exclusively on Shanghai Pharmaceuticals' fundamentals will not take into account other important factors: Shanghai Pharmaceuticals Total Value Analysis
Shanghai Pharmaceuticals Holding is at this time expected to have takeover price of 9.42 B with market capitalization of 9.2 B, debt of 7.16 B, and cash on hands of 37.3 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Shanghai Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.42 B | 9.2 B | 7.16 B | 37.3 B |
Shanghai Pharmaceuticals Investor Information
The company has price-to-book ratio of 0.69. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Shanghai Pharmaceuticals has Price/Earnings To Growth (PEG) ratio of 2.52. The entity last dividend was issued on the 21st of July 2022. Based on the key indicators related to Shanghai Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Shanghai Pharmaceuticals Holding is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Shanghai Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Shanghai Pharmaceuticals has an asset utilization ratio of 132.05 percent. This suggests that the Company is making $1.32 for each dollar of assets. An increasing asset utilization means that Shanghai Pharmaceuticals Holding is more efficient with each dollar of assets it utilizes for everyday operations.Shanghai Pharmaceuticals Profitability Analysis
The company reported the revenue of 215.82 B. Net Income was 5.09 B with profit before overhead, payroll, taxes, and interest of 28.41 B.About Shanghai Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of Shanghai Pharmaceuticals. We calculate exposure to Shanghai Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Shanghai Pharmaceuticals's related companies.Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the Peoples Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical Co., Ltd. Shanghai Pharmaceuticals operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 46577 people.
8 Steps to conduct Shanghai Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Shanghai Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Shanghai Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Shanghai Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Shanghai Pharmaceuticals' revenue streams: Identify Shanghai Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Shanghai Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Shanghai Pharmaceuticals' growth potential: Evaluate Shanghai Pharmaceuticals' management, business model, and growth potential.
- Determine Shanghai Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Shanghai Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Shanghai Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 2.8 B | |
| Quarterly Earnings Growth Y O Y | 0.024 | |
| Forward Price Earnings | 8.3612 | |
| Retained Earnings | 30.6 B |
Additional Tools for Shanghai Pink Sheet Analysis
When running Shanghai Pharmaceuticals' price analysis, check to measure Shanghai Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Pharmaceuticals is operating at the current time. Most of Shanghai Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Shanghai Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shanghai Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.